Madrigal Pharmaceuticals
MDGL
#2088
Rank
โ‚น815.99 B
Marketcap
โ‚น35,127
Share price
-4.45%
Change (1 day)
-28.45%
Change (1 year)

Revenue for Madrigal Pharmaceuticals (MDGL)

Revenue in 2026 (TTM): โ‚น133.87 Billion

According to Madrigal Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is โ‚น132.31 Billion. In 2025 the company made a revenue of โ‚น86.03 Billion an increase over the revenue in the year 2024 that were of โ‚น15.45 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Madrigal Pharmaceuticals from 2008 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚น133.87 B55.6%
2025 โ‚น86.03 B456.75%
2024 โ‚น15.45 B
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A
2015 N/A
2014 N/A
2013 N/A-100%
2012 โ‚น8.04 M-97.99%
2011 โ‚น0.40 B-39.52%
2010 โ‚น0.66 B-90.09%
2009 โ‚น6.69 B2937.7%
2008 โ‚น0.22 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
OPKO Health
OPK
โ‚น46.48 B-64.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
โ‚น20.94 M-99.98%๐Ÿ‡บ๐Ÿ‡ธ USA